1.Dengue: an overview
Sekaran SD ; Rathakrishnan A ; Yeo ASL
Journal of University of Malaya Medical Centre 2014;17(2):23-32
Dengue is one of the highest occurring vector-borne diseases. It is caused by dengue viruses 1- 4. Currently,
the disease is classified into dengue with or without warning signs and severe dengue based on WHO 2009
dengue classification. As of today, neither specific drugs nor commercial vaccine exist for dengue. The best
treatment yet would be support, management and proper medical care. With no pathognomonic features
that could differentiate it from other febrile illnesses, clinical diagnosis alone is insufficient. Yet, despite the
current advances and existence of various laboratory diagnostic methods of dengue, a consensus singular
method has not been established. There are several hypotheses or theories regarding the vaguely understood
immunopathogenesis of dengue. Amongst these are the viral factors, host-immune factors and host-genetic
factors. In addition to these, the occurrence of asymptomatic dengue has further complicated the disease.
However, these individuals provide opportunities in the search for protective factors against dengue.
Dengue
3.Validation of transcranial Doppler with CT angiography in cerebral ischaemia: a preliminary pilot study in Singapore.
Rahul RATHAKRISHNAN ; Yeh I BERNE ; Keng K QUEK ; Chiew S HONG ; Benjamin Kc ONG ; Bernard Pl CHAN ; Vijay K SHARMA
Annals of the Academy of Medicine, Singapore 2008;37(5):402-405
INTRODUCTIONTranscranial Doppler (TCD) is an established tool for the non-invasive assessment of cerebral blood flow. Since TCD results vary with the skills and experience of the sonographer, it requires validation against contrast angiography. We evaluated the diagnostic accuracy of TCD against computed tomography angiography (CTA) and the feasibility of the latter as an additional screening tool in our acute ischaemic stroke patients.
MATERIALS AND METHODSOur stroke unit manages about 700 patients annually. Acute stroke patients undergo TCD for vascular assessment of major arteries of the circle of Willis. Randomly selected acute stroke patients with significant stenosis on TCD underwent high-resolution cranial CTA with multidetector helical scanner. CTA was performed within 24 hours of TCD and images were interpreted by a neuroradiologist blinded to TCD findings. An independent neurosonologist reevaluated TCD if CTA findings were contradictory. Additional information by either modality was also noted.
RESULTSFifteen patients (12 men, mean age 61 +/- 15years) with cerebral ischaemia and moderate (>50%) stenosis in > or =1 large intracranial arterial segment on routine TCD were evaluated by CTA. Compared with 21 segments of significant stenosis on CTA, TCD showed 16 true-positive, 3 false-positive and 5 false-negative results (sensitivity: 76.2%, positive predictive value: 84.2%). In 3 cases, TCD showed findings complementary to CTA (real-time embolisation, collateral flow patterns, evidence of distal M2 branch occlusion).
CONCLUSIONTCD in our neurovascular laboratory shows a satisfactory agreement with cranial CTA in evaluating patients with cerebral ischaemia. TCD can provide additional real-time dynamic findings complementary to information provided by CTA.
Aged ; Brain Ischemia ; diagnosis ; Cerebral Angiography ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Singapore ; Tomography, X-Ray Computed ; Ultrasonography, Doppler, Transcranial
4.POEMS syndrome--a case for more aggressive treatment.
Rahul RATHAKRISHNAN ; Te-Chih LIU ; Yee-Cheun CHAN ; Benjamin K C ONG
Annals of the Academy of Medicine, Singapore 2007;36(6):435-437
INTRODUCTIONPatients with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal or M-protein and skin changes) syndrome exhibit a wide range of clinical manifestations and are often seen by a variety of specialists prior to diagnosis.
CLINICAL PICTUREWe describe a case of POEMS syndrome that first presented with significant neuropathy but progressed to develop further manifestations of the condition, including marked gastrointestinal symptoms.
TREATMENTThe patient was commenced on localised radiotherapy and chemotherapy in addition to immunomodulatory therapy for the neuropathy.
CONCLUSIONWe highlight several learning points that may benefit physicians from varied specialties. This case is also unique for its marked gastrointestinal manifestation. To our knowledge, this is the second reported case in the literature with this feature.
Gastrointestinal Diseases ; etiology ; physiopathology ; Humans ; Immunologic Factors ; therapeutic use ; Male ; Middle Aged ; POEMS Syndrome ; complications ; drug therapy ; radiotherapy ; Treatment Outcome
5.Ultrasound assisted thrombolysis in acute ischaemic stroke: preliminary experience in Singapore.
Vijay K SHARMA ; Rahul RATHAKRISHNAN ; Benjamin K C ONG ; Bernard P L CHAN
Annals of the Academy of Medicine, Singapore 2008;37(9):778-782
BACKGROUND AND AIMIntravenously-administered tissue plasminogen activator (IV-TPA) induces thrombolysis and remains the only FDA-approved therapy for acute ischaemic stroke. IV-TPA thrombolysis has been approved recently in Singapore for acute stroke. Continuous exposure of clot to 2-MHz pulsed-wave transcranial Doppler (TCD) ultrasound during IV-TPA infusion is known to augment thrombolysis. We aimed to determine the feasibility, safety and efficacy of ultrasound-assisted thrombolysis in acute ischaemic stroke in Singapore.
SUBJECTS AND METHODSConsecutive patients with acute ischaemic stroke due to intracranial arterial-occlusions were treated with standard IV-tPA and continuously monitored with 2-MHz TCD according to the CLOTBUST-trial protocol. Arterial recanalisation was determined with Thrombolysis in Brain Ischemia (TIBI) flow-grading system. Safety and efficacy of ultrasoundassisted thrombolysis were assessed by rates of symptomatic intracranial haemorrhage (sICH) and functional recovery at 1 month, respectively.
RESULTSFive consecutive patients (mean age 58 years, 3 men and 3 of Chinese ethnicity) were included. Mean time elapsed between symptom onset and presentation to emergency room was 98 minutes (range, 50 to 135 minutes) while the mean time interval between symptom onset to IV-TPA bolus was 144 minutes (range, 125 to 180 minutes). Partial or complete recanalisation with reduction in the stroke severity was noted in 4 out of the 5 patients during IV-TPA infusion (mean change in NIHSS = 4 points; range 2 to 8 points). None of our patients developed sICH while 4 patients demonstrated good functional outcome at 1 month.
CONCLUSIONSOur preliminary study demonstrates the feasibility, safety and efficacy of ultrasound-assisted thrombolysis in acute ischaemic stroke in Singapore. Continuous TCD-monitoring during IV-TPA infusion provides real-time information, enhances thrombolysis and improves functional outcomes in acute ischaemic stroke.
Aged ; Brain Infarction ; diagnostic imaging ; Female ; Fibrinolytic Agents ; administration & dosage ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Thrombolytic Therapy ; methods ; Tissue Plasminogen Activator ; administration & dosage ; Ultrasonography, Interventional ; methods
6.Localising Median Neuropathies: The Role of Different Investigations.
Leonard Ll YEO ; Rahul RATHAKRISHNAN ; Vijayan JOY ; Aravinda T KANNAN ; Einar Wilder SMITH
Annals of the Academy of Medicine, Singapore 2015;44(9):350-352
Arteriovenous Shunt, Surgical
;
adverse effects
;
Brachial Artery
;
diagnostic imaging
;
Diabetic Nephropathies
;
complications
;
therapy
;
Hematoma
;
complications
;
diagnostic imaging
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Median Neuropathy
;
diagnostic imaging
;
etiology
;
physiopathology
;
Middle Aged
;
Neural Conduction
;
Renal Dialysis
;
Ultrasonography
7.A Prospective Cohort Study of Laboratory Abnormalities During Isotretinoin Treatment For Acne Vulgaris
Kanimoli Rathakrishnan ; Lay Kim Tan ; Sharifah Rosniza Binti Syed Nong Chek ; Che Hassan Zuraida ; Dyoi E Low
Malaysian Journal of Dermatology 2022;48(Jun 2022):17-24
Background:
Acne vulgaris is a chronic inflammatory condition of the pilosebaceous unit. Isotretinoin is used to
treat moderate to severe acne that is resistant to antibiotics and topical agents. However, it may cause
alterations in lipids and liver enzymes.
Methods:
A total of 129 patients with acne vulgaris (moderate to severe facial acne) treated with isotretinoin
were recruited between May 2020 and July 2021 from the dermatology clinics at Hospital Serdang
and Hospital Kuala Lumpur. Of these, 120 patients with complete data of lipid panel (total cholesterol,
low density lipoprotein cholesterol [LDL], triglycerides [TG], and high density lipoprotein cholesterol
[HDL]) and hepatic panel (alanine transaminase [ALT] and aspartate transaminase [AST]) levels at
baseline, and in three subsequent follow-up visits (i.e., one, three, and six months) were included in
the analyses. Abnormalities were graded according to standard laboratory values and their severity
according to the National Cancer Institute Common Terminology Criteria for Adverse Events
(CTCAE)grading system.
Results:
Of the 120 study participants, 83% were female and 37% were male between the ages of 15 and 36
years. We observed a significant increase in median values at baseline and at the six-month follow-up
for total cholesterol (p<0.0001), triglycerides (p<0.0001), LDL (p<0.0001), ALT (p<0.0001), and
AST (p<0.0001). We observed a significant correlation between body mass index and the HDL (r2
=-
0.26, p=0.01) and ALT (r2
=0.383, p=7.9x10-06) levels. Based on the CTCAE grading system, almost
all study participants with abnormal results had grade 1 abnormalities. Only one patient had a grade 2
abnormality in ALT, which required treatment discontinuation.
Conclusion
Low dose isotretinoin therapy for acne vulgaris may cause mild and non-progressive elevation of
LDL, total cholesterol, and liver transaminases which do not require treatment withdrawal in most
cases.
Isotretinoin--therapeutic use
;
Acne Vulgaris-therapy